SCALONE, LUCIANA
 Distribuzione geografica
Continente #
NA - Nord America 5.616
EU - Europa 2.966
AS - Asia 2.933
SA - Sud America 468
AF - Africa 55
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.050
Nazione #
US - Stati Uniti d'America 5.476
SG - Singapore 1.397
CN - Cina 662
IT - Italia 521
DE - Germania 498
RU - Federazione Russa 453
HK - Hong Kong 437
BR - Brasile 390
SE - Svezia 390
IE - Irlanda 298
UA - Ucraina 230
GB - Regno Unito 158
VN - Vietnam 153
CA - Canada 114
AT - Austria 90
DK - Danimarca 77
IN - India 72
FI - Finlandia 71
FR - Francia 49
TR - Turchia 37
NL - Olanda 33
AR - Argentina 30
ZA - Sudafrica 28
ID - Indonesia 27
BD - Bangladesh 25
BE - Belgio 23
JP - Giappone 18
MX - Messico 18
ES - Italia 17
PL - Polonia 14
KR - Corea 13
AE - Emirati Arabi Uniti 12
IQ - Iraq 12
PK - Pakistan 12
VE - Venezuela 11
CO - Colombia 10
EC - Ecuador 10
KE - Kenya 10
IR - Iran 9
CH - Svizzera 8
SA - Arabia Saudita 7
BG - Bulgaria 6
CL - Cile 6
CZ - Repubblica Ceca 6
TW - Taiwan 6
AU - Australia 4
BO - Bolivia 4
DZ - Algeria 4
EU - Europa 4
JO - Giordania 4
LT - Lituania 4
RS - Serbia 4
BH - Bahrain 3
HU - Ungheria 3
LB - Libano 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IL - Israele 2
MA - Marocco 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
TH - Thailandia 2
UY - Uruguay 2
A1 - Anonimo 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
YE - Yemen 1
Totale 12.050
Città #
Ann Arbor 700
Singapore 576
Woodbridge 491
Hong Kong 436
Ashburn 430
Chandler 368
Fairfield 344
Houston 311
Frankfurt am Main 286
Dublin 283
Jacksonville 229
Wilmington 226
Dearborn 194
New York 175
Seattle 143
Milan 137
Santa Clara 134
Princeton 128
Beijing 120
Cambridge 116
Dallas 104
Vienna 85
Los Angeles 74
Nanjing 66
The Dalles 60
Altamura 57
Lawrence 54
Shanghai 54
Moscow 40
Ho Chi Minh City 39
Lachine 37
Fremont 33
Buffalo 32
Chicago 32
Hanoi 31
Guangzhou 30
Rome 29
Helsinki 27
Council Bluffs 26
San Diego 26
São Paulo 26
Shenyang 23
Toronto 22
Andover 21
Columbus 21
Hefei 21
Tianjin 21
Munich 20
Ottawa 20
Jakarta 19
London 19
Dong Ket 18
Jinan 18
Boston 17
Changsha 17
Brussels 16
Hebei 16
Nanchang 16
Jiaxing 15
Orem 14
Brooklyn 13
Salt Lake City 13
Johannesburg 12
San Jose 12
Tokyo 12
Zhengzhou 12
Mountain View 11
Brasília 10
Haiphong 10
Manchester 10
Ningbo 10
Redmond 10
Hangzhou 9
Nairobi 9
Warsaw 9
Bonndorf 8
Falls Church 8
Nürnberg 8
Phoenix 8
Rio de Janeiro 8
Stockholm 8
Valencia 8
Angri 7
Atlanta 7
Belo Horizonte 7
Boardman 7
Edmonton 7
Huizen 7
Montreal 7
Poplar 7
Porto Alegre 7
Ankara 6
Biên Hòa 6
Busto Arsizio 6
Chennai 6
Dhaka 6
Dubai 6
Elk Grove Village 6
Guayaquil 6
Kunming 6
Totale 7.478
Nome #
Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population 415
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 398
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 336
Use of health care administrative databases to estimate the burden of breast cancer. 324
Use of health care administrative databases to estimate the burden of multiple sclerosis: a population-based study 318
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 277
Health related quality of life in chronic liver diseases 276
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 264
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 261
Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 258
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 255
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 251
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 249
The impact of liver disease on the health-related quality of life 246
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 243
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting 238
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 235
Health Related Quality of Life in the Major Liver Conditions 235
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 234
Sustainability of the Italian National Health Service 231
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 227
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 227
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 218
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 217
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 213
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases 212
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 211
Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study) 207
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 206
Difference in health related quality of life of chronic liver diseases and general population 206
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 205
Il burden delle polmoniti: analisi dai database amministrativi (DENALI) della regione Lombardia. 199
Health related quality of life norm data of the general population in Italy: Results using the EQ-5D-3L and EQ-5D-5L instruments 190
Development of a segmentation model to identify healthcare demand and related costs attributable to population's characteristics 186
Utilization of disease modifying agents in multiple sclerosis: from an Italian administrative database. 184
Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases 181
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 179
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: Results from Italy 175
Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases 175
Italian population-based values of EQ-5D health states 170
Analisi della domanda di salute attraverso l’impiego di database amministrativi regionali 166
Utilization of antispasticity drugs in multiple sclerosis: analysis from an Italian administrative database 163
Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens 160
Use of health care administrative databases to estimate incidence of foot complications in diabetes patients 158
Use of healthcare administrative databases to estimate the burden of diabaetes mellitus: a population-based study 156
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: The COCIS study group 147
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study 147
Impatto dei trend demografici ed epidemiologici sulla sostenibilità del SSN. 137
Obsessive compulsive tic disorder: Appropriate diagnosis and treatment as key elements to improve health and rationalize use of resources 137
Use of health care administrative databases to estimate the health care burden of bone or bone marrow metastatic disease in breast cancer patients: a population-based study. 135
Use of health care administrative databases to estimate the burden of diabetes mellitus: a population-based study 123
The societal burden of chronic liver diseases: Results from the COME study 121
Clinical use, quality of life and cost-effectiveness of spinal cord stimulation used to treat patients with failed back surgery syndrome 120
Regarding "exploring patient involvement in decision making for vascular procedures" 119
Use of health care administrative databases to estimate the health care burden of bone or bone marrow metastatic disease in breast cancer patients: a population-based study 113
Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study 113
Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids 112
Use of health-related quality-of-life measurements to estimate individuals' health on screening 112
Patient Preferences and Willingness to Pay for different Options of Anticoagulant Therapy 111
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: A discrete choice experiment 99
Cost-effectiveness analysis of new drugs for chronic hepatitis C: The importance of updating utility values 98
Preferences of patients, their family caregivers and vascular surgeons in the choice of abdominal aortic aneurysms treatment options: The PREFER study 90
Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: Results from the COHIBA Study 87
Totale 12.456
Categoria #
all - tutte 43.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021558 0 0 0 0 0 72 91 76 95 86 71 67
2021/2022711 39 59 88 68 37 62 28 60 43 48 49 130
2022/20231.451 156 493 130 123 77 217 11 90 87 5 45 17
2023/2024890 32 30 26 49 98 258 168 20 81 11 10 107
2024/20252.444 131 221 124 96 205 101 155 54 291 307 337 422
2025/20262.336 558 228 378 426 541 205 0 0 0 0 0 0
Totale 12.456